Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region.
Autore F, Innocenti I, Corrente F, Del Principe MI, Rosati S, Falcucci P, Fresa A, Conte E, Limongiello MA, Renzi D, De Padua L, Andriani A, Pisani F, Cimino G, Tafuri A, Montanaro M, Mauro FR, Del Poeta G, Laurenti L. Autore F, et al. Among authors: falcucci p. Front Oncol. 2020 Jun 10;10:848. doi: 10.3389/fonc.2020.00848. eCollection 2020. Front Oncol. 2020. PMID: 32587827 Free PMC article.
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.
Laurenti L, De Padua L, Tarnani M, Piccirillo N, Falcucci P, D'Arena G, Innocenti I, Marietti S, Efremov DG, Chiusolo P, Zini G, Sora' F, Sica S, Leone G. Laurenti L, et al. Among authors: falcucci p. Ann Hematol. 2011 Jan;90(1):59-65. doi: 10.1007/s00277-010-1025-y. Epub 2010 Jul 13. Ann Hematol. 2011. PMID: 20625902
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome.
De Padua L, Laurenti L, Falcucci P, D'arena G, Vannata B, Innocenti I, Autore F, Piccirillo N, Za T, Marietti S, Efremov DG, Sica S. De Padua L, et al. Among authors: falcucci p. Ann Hematol. 2014 Jul;93(7):1261-2. doi: 10.1007/s00277-013-1968-x. Epub 2013 Dec 5. Ann Hematol. 2014. PMID: 24306088 No abstract available.
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12.
Autore F, Strati P, Innocenti I, Corrente F, Trentin L, Cortelezzi A, Visco C, Coscia M, Cuneo A, Gozzetti A, Mauro FR, Frustaci AM, Gentile M, Morabito F, Molica S, Falcucci P, D'Arena G, Murru R, Vincelli D, Efremov DG, Ferretti A, Rigolin GM, Vitale C, Tisi MC, Reda G, Visentin A, Sica S, Foà R, Ferrajoli A, Laurenti L. Autore F, et al. Among authors: falcucci p. Cancers (Basel). 2019 Jun 26;11(7):896. doi: 10.3390/cancers11070896. Cancers (Basel). 2019. PMID: 31248056 Free PMC article.
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas.
Marchesi F, Pimpinelli F, Giannarelli D, Ronchetti L, Papa E, Falcucci P, Pontone M, Di Domenico EG, di Martino S, Laquintana V, Mandoj C, Conti L, Cordone I, La Malfa A, Viggiani C, Renzi D, Palombi F, Romano A, Pisani F, Gumenyuk S, Di Bella O, Vujovic B, Morrone A, Ciliberto G, Ensoli F, Mengarelli A. Marchesi F, et al. Among authors: falcucci p. Leukemia. 2022 Feb;36(2):588-590. doi: 10.1038/s41375-021-01418-8. Epub 2021 Sep 20. Leukemia. 2022. PMID: 34545184 Free PMC article. No abstract available.
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience.
Autore F, Stirparo L, Innocenti I, Papa E, Marchesi F, Togni C, Mariani S, Torrieri L, Salvatori M, Fazio F, Metafuni E, Giammarco S, Sora F, Falcucci P, Ferrari A, Trisolini SM, Capria S, Tafuri A, Chiusolo P, Sica S, Laurenti L. Autore F, et al. Among authors: falcucci p. Front Oncol. 2022 Dec 2;12:897937. doi: 10.3389/fonc.2022.897937. eCollection 2022. Front Oncol. 2022. PMID: 36531008 Free PMC article.
Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim.
Marchesi F, Terrenato I, Papa E, Tomassi M, Falcucci P, Gumenyuk S, Palombi F, Pisani F, Renzi D, Romano A, Spadea A, Regazzo G, Rizzo MG, De Rienzo M, Ripellino C, Sgromo S, Viggiani C, Ponte E, Kayal R, Cordone I, Foddai ML, Mengarelli A. Marchesi F, et al. Among authors: falcucci p. Ann Hematol. 2024 Mar;103(3):947-956. doi: 10.1007/s00277-023-05604-9. Epub 2024 Jan 8. Ann Hematol. 2024. PMID: 38189833 Free PMC article.
NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey.
Pagano L, Gallamini A, Trapè G, Fianchi L, Mattei D, Todeschini G, Spadea A, Cinieri S, Iannitto E, Martelli M, Nosari A, Bona ED, Tosti ME, Petti MC, Falcucci P, Montanaro M, Pulsoni A, Larocca LM, Leone G; Intergruppo Italiano Linfomi. Pagano L, et al. Among authors: falcucci p. Ann Oncol. 2006 May;17(5):794-800. doi: 10.1093/annonc/mdl015. Epub 2006 Feb 23. Ann Oncol. 2006. PMID: 16497823 Free article.
24 results